ROC curve analysis (AUC = 0.749) supported hepcidin-25 as a valuable biomarker for the assessment of inflammation activity in IBD patients and an indicator of whether the patient will be in the first group (anemia) or in the second group (gut inflammation is dominant) (Figure 3). Here, HAMP is linked to anemia.